Efficacy of botulinum toxin type A in myogenic temporomandibulardisorders: a single arm, prospective, pilot study
{{output}}
Background: Myogenous temporomandibular disorders (TMDs) is commonly associated with myofascial pain and functional limitations. Botulinum toxin type A (BoNT-A) has shown potential in relieving chronic muscular pain. ... ...
